Keyphrases
Newly Diagnosed
100%
Acute Myeloid Leukemia
100%
Induction Chemotherapy
100%
Leukemia Patients
100%
Linezolid
100%
Hematologic Recovery
100%
Antimicrobial
33%
Hematologic
33%
Gram-positive
33%
Neutrophil Recovery
33%
Acute Leukemia
22%
Vancomycin
22%
Antimicrobial Therapy
22%
Gram-negative
22%
Daptomycin
22%
Inclusion Criteria
11%
Neutropenia
11%
No Significant Difference
11%
Observational Cohort Study
11%
Large Population
11%
Platelet Count
11%
Chemotherapy
11%
Tertiary Care
11%
Length of Hospital Stay
11%
Newly Diagnosed Patients
11%
Academic Medical Centers
11%
Median Time
11%
Recovery Time
11%
Single Center
11%
ICD-9
11%
Well-defined
11%
Subgroup Analysis
11%
Potential Adverse Effects
11%
Measurement Results
11%
Computerized Physician Order Entry System
11%
ARM-based
11%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Induction Chemotherapy
100%
Linezolid
100%
Antiinfective Agent
33%
Neutrophil
33%
Acute Leukemia
22%
Vancomycin
22%
Antimicrobial Therapy
22%
Daptomycin
22%
Tertiary Care
11%
Neutropenia
11%
Arm
11%
Cohort Study
11%
Platelet
11%
ICD-9
11%
Subgroup Analysis
11%
Computerized Physician Order Entry
11%
Adverse Effect
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Acute Myeloid Leukemia
100%
Linezolid
100%
Antiinfective Agent
44%
Vancomycin
22%
Acute Leukemia
22%
Daptomycin
22%
Cohort Study
11%
Neutropenia
11%
Antimicrobial Therapy
11%
ICD-9
11%
Immunology and Microbiology
Myeloid
100%
Neutrophil
75%
Arm
25%
Platelet Count
25%
ICD-9
25%
Computerized Provider Order Entry
25%